PTEN and breast cancer: LncARSR promoted doxorubicin resistance in HCC cells via PTEN-PI3K/Akt pathway [27], and miRNA-130b targeted PTEN to mediate chemoresistance to adriamycin in breast cancer cells via PI3K/Akt pathway [28].